What is cerebral palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Cerebral Palsy

Cerebral palsy is a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. 1, 2, 3

Core Characteristics

Cerebral palsy represents the most common physical disability in childhood, affecting approximately 2 to 3 cases per 1000 live births in high-income countries. 4, 2 The condition is fundamentally a clinical diagnosis rather than a single disease entity, encompassing children who share features of a non-progressive brain injury or lesion acquired during the antenatal, perinatal, or early postnatal period. 5

Essential Diagnostic Features

The diagnosis requires the presence of motor dysfunction characterized by:

  • Reduced quality of movement 3
  • Neurologically abnormal movements 3
  • Motor activities substantially below chronological age expectations 3

The brain disturbance itself is non-progressive, though secondary complications can develop over time without appropriate intervention. 1

Clinical Presentation and Motor Types

The motor impairments manifest in distinct patterns:

Spasticity is the predominant form, occurring in 85-91% of cases. 2 Other motor types include:

  • Dyskinesia (4-7%), encompassing dystonia and athetosis 2
  • Ataxia (4-6%) 2
  • Hypotonia (2%) 2

The anatomical distribution varies:

  • Unilateral/hemiplegia: 38% 2
  • Bilateral diplegia (lower limbs more affected): 37% 2
  • Quadriplegia (all four limbs and trunk): 24% 2

Motor types emerge and evolve during the first 2 years of life, making early classification challenging but not impossible. 1

Associated Conditions and Comorbidities

Cerebral palsy frequently coexists with other neurodevelopmental disorders and medical conditions:

  • Chronic pain: 75% 2
  • Intellectual disability: 27-49% 4, 2
  • Epilepsy: 35-38% 4, 2
  • Speech disorders: 33-82% 4
  • Hip displacement: 28% 2
  • Behavioral disorders: 26% 2
  • Sleep disorders: 23% 2
  • Visual impairment: 11% 2
  • Hearing impairment: 4% 2
  • Autism spectrum disorder: 3-9% 4

Etiology and Risk Factors

The underlying cause of cerebral palsy is uncertain in most cases, and birth asphyxia accounts for less than 10% of cases despite historical assumptions. 4

Contributing factors include:

  • Genetic variants (14% of cases have a genetic component) 2
  • Prematurity and low birth weight 4
  • Maternal conditions: thyroid disease, preeclampsia, infections 2
  • Intrauterine growth restriction and multiple gestation 2
  • Preconception risks: history of stillbirths, miscarriages, low socioeconomic status, assisted reproduction 2
  • Infections, trauma, stroke, and hypoxic events in early infancy 2

Recent evidence demonstrates that rare genomic variants contribute significantly to etiology, with exome sequencing revealing pathogenic variants in 31.1% of cases. 4

Neuroimaging Patterns

The most predictive MRI patterns include:

  • White matter injury (cystic periventricular leukomalacia or periventricular hemorrhagic infarctions): 56% 2
  • Cortical and deep gray matter lesions (basal ganglia, thalamus, watershed injury, multicystic encephalomalacia, stroke): 18% 2
  • Brain maldevelopments (lissencephaly, pachygyria, cortical dysplasia, polymicrogyria, schizencephaly): 9% 2

Timing of Diagnosis

Diagnosis can now be made before 6 months' corrected age using standardized assessment tools in combination with clinical history, representing a significant advancement from the traditional diagnosis window of 12-24 months. 1

Before 5 months' corrected age, the most predictive tools are:

  • Term-age MRI (86-89% sensitivity) 1
  • Prechtl Qualitative Assessment of General Movements (98% sensitivity) 1
  • Hammersmith Infant Neurological Examination (90% sensitivity) 1

After 5 months' corrected age:

  • MRI (86-89% sensitivity) 1
  • Hammersmith Infant Neurological Examination (90% sensitivity) 1
  • Developmental Assessment of Young Children (83% C index) 1

Prognosis and Long-Term Outcomes

Two in three individuals with cerebral palsy will walk, three in four will talk, and one in two will have normal intelligence. 2

Mortality risk increases with the number of associated impairments, including intellectual disability, limb function limitations, hearing impairment, and vision impairment. 6 Respiratory diseases and aspiration pneumonia are the leading causes of death, particularly in individuals with swallowing dysfunction. 2

Management Principles

Early diagnosis and prompt referral to diagnostic-specific intervention is essential to optimize infant motor and cognitive plasticity, prevent secondary complications, and enhance caregiver well-being. 2 Early intervention should begin as soon as cerebral palsy is suspected rather than waiting for definitive diagnosis. 2

References

Guideline

Cerebral Palsy Definition and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cerebral Palsy Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Cerebral Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cerebral palsy.

Nature reviews. Disease primers, 2016

Research

Diagnosis, treatment, and prevention of cerebral palsy.

Clinical obstetrics and gynecology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.